Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hana Micron (067310) – Setting of Closure Period of Shareholders’ Register or Record Date / 2024-05-17 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-07-31 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-05-30 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | NAND Pricing · Fab Utilization · Earnings Upgrades / 2026-01-07 RESEARCH
  • [Disclosure] Jusung Engineering(036930) – (Correction) Split Decision (Spin-off) / 2024-07-04 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Paid-in Capital Increase Decision / 2025-11-24 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Cash/In-Kind Dividend / 2025-02-12 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2025-02-03 Disclosures

Category: Disclosures

[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Capital Increase by Subsidiary / 2024-12-30

Posted on December 30, 2024August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Capital Increase by Subsidiary / 2024-12-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has filed a corrected disclosure updating the authorized share limit to 10,000 shares and changing the payment date to undecided (to be disclosed via amended filing once finalized) regarding the capital increase of its subsidiary (Hanwha Ocean USA Holdings Corp.). 📊 [Key Disclosure Details…

Read More “[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Capital Increase by Subsidiary / 2024-12-30” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-30

Posted on December 30, 2024August 11, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-30

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has amended its ‘TICN 4th Mass Production’ supply contract with the Defense Acquisition Program Administration (DAPA). The contract value increased from approx. KRW 612.2B to KRW 650.5B (up by approx. KRW 38.3B), and the contract end date was extended to November 30, 2026. 📊…

Read More “[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-30” »

Disclosures, Defense

[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2024-12-27

Posted on December 27, 2024August 11, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2024-12-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a supply contract worth approx. KRW 82.2B with its largest shareholder, Hanwha Aerospace, for ‘Automatic Fire Control System and C2 System for Egypt K9/K11’. This represents 3.35% of its recent annual revenue, covering the period from December 26, 2024, to December 29,…

Read More “[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2024-12-27” »

Disclosures, Defense

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-27

Posted on December 27, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received Phase 3 Clinical Trial Application (IND) approval from the US Food and Drug Administration (FDA) for CT-P44, a biosimilar candidate referencing Darzalex. 약업신문 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Clinical Trial Progress and Patient Recruitment…

Read More “[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-27” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-12-27

Posted on December 27, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-12-27

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided to acquire 546,747 treasury common shares worth approximately KRW 100.0B through on-market purchases to stabilize its stock price and enhance shareholder value. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of On-Market Purchases and Completion of Acquisition…

Read More “[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-12-27” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Debt Guarantee for Others / 2024-12-26

Posted on December 26, 2024August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Debt Guarantee for Others / 2024-12-26

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has filed a corrected disclosure updating the start date of its KRW 180.0B debt guarantee (indemnification obligation in case of failure to achieve completion) for Hyundai Oil Terminal Ulsan Co., Ltd. from December 31, 2024, to January 14, 2025. 📊 [Key Disclosure Details &…

Read More “[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Debt Guarantee for Others / 2024-12-26” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-26

Posted on December 26, 2024August 11, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-26

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has amended its ‘TICN 4th Mass Production’ supply contract with the Defense Acquisition Program Administration (DAPA). The contract value increased from approx. KRW 606.0B to KRW 612.2B (up by approx. KRW 6.27B), and the contract end date was extended to December 31, 2025. 📊…

Read More “[Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-26” »

Disclosures, Defense

[Disclosure] Celltrion (068270) – Notice of Ex-Dividend Reference Price / 2024-12-26

Posted on December 26, 2024August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Notice of Ex-Dividend Reference Price / 2024-12-26

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The Korea Exchange set and announced the ex-dividend reference price for Celltrion’s common shares at KRW 182,900, effective December 27, 2024, to reflect its stock dividend. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Ex-Dividend Reference Price Implementation…

Read More “[Disclosure] Celltrion (068270) – Notice of Ex-Dividend Reference Price / 2024-12-26” »

Disclosures, Bio & Healthcare

[Disclosure] ALTEOGEN (196170) – Results of Extraordinary General Shareholders Meeting / 2024-12-26

Posted on December 26, 2024August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – Results of Extraordinary General Shareholders Meeting / 2024-12-26

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary At Alteogen’s Extraordinary General Meeting of Shareholders, a single agenda item regarding amendments to the Articles of Incorporation (Agenda 1) was approved as originally submitted. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Approved Articles of Incorporation Amendments…

Read More “[Disclosure] ALTEOGEN (196170) – Results of Extraordinary General Shareholders Meeting / 2024-12-26” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-12-26

Posted on December 26, 2024August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-12-26

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has disclosed a supply contract with LIG Nex1 valued at approximately KRW 318.4B for the mass production of missile internal components and launch tubes under the SA-MSAM project. 📊 [Key Disclosure Contents & Major Financial Figures] 1. Contract Details and Value 2. Contract Partner…

Read More “[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2024-12-26” »

Disclosures, Defense

Posts pagination

Previous 1 … 164 165 166 … 252 Next
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | 4Q23 Seasonality · 1Q24 Inflection · Non-IT Portfolio Growth / 2024-02-01 Semiconductors
  • [Disclosure] HPSP (403870) – Decision on Cash and In-Kind Dividend / 2025-02-13 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-08 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Solidigm Monetization · Shareholder Returns · Valuation Appeal / 2026-08-11 RESEARCH
  • [Disclosure] ISU PETASYS(007660) – Investor Relations (IR) Holding Announcement / 2025-03-21 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Change in Representative Director (Executive Officer) / 2024-05-21 Semiconductors
  • [Disclosure] SK Square (402340) – (Correction) Decision on Issuance of Depositary Receipts / 2026-07-10 Disclosures
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme